December 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreMarch 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreNovember 01, 2025
Market insights predict, the Europe dermal filler industry is expected to grow from USD 1.84 billion in 2024 to USD 4.23 billion by 2034, driven by a CAGR of 8.84%. The Europe dermal filler market is growing due to rising focus on beauty standards....
November 01, 2025
Based on market forecasts, the primary progressive multiple sclerosis sector will expand from USD 1.29 billion in 2024 to USD 5.11 billion by 2034, experiencing a CAGR of 14.84%. The primary progressive multiple sclerosis market is growing as increased spending in the advanced research of neurodegenerative diseases is significant for discovering no...
November 01, 2025
The multiple modalities in oncology market is expanding due to increasing tumor heterogeneity as well as growing treatment approaches. North America led the market due to the presence of the advanced healthcare sector....
November 01, 2025
The advanced therapies in biopharmaceutical medicine market is expanding due to increasing diseases as well as growing gene editing therapies. North America led the market due to the presence of a well-developed healthcare sector....
November 01, 2025
The CAR-T cell therapy isolator market is growing due to CAR-T cell therapy isolators providing benefits for manufacturers to affordable and safe production environment for the manufacturing of CAR-T cells....
November 01, 2025
Based on market forecasts, the global viral vector gene therapy market, projected at USD 13.14 billion in 2024, is expected to reach USD 38.39 billion by 2034, growing at a CAGR of 11.23% over the forecast period. The viral vector gene therapy market is growing due to rising demand for targeted treatments for genetic and rare diseases. Advancements...
November 01, 2025
Around the world, the sex-based drug development market is driven by the rising approaches to sex-based differences, like pharmacokinetic, pharmacodynamic, and hormonal characteristics. Whereas, North America dominated the global market, with a growing number of research activities and an increasing focus on personalized approaches in drug developm...
November 01, 2025
Projections indicate that, the global rare disease treatment market will increase from USD 195.21 billion in 2024 to USD 587.08 billion by 2034, experiencing a CAGR of 11.64% over the next 10 years.The rising prevalence of rare diseases and growing research and development activities foster market growth. North America dominated the global market o...
November 01, 2025
The temperature-sensitive drug market is expanding due to increasing vaccination as well as growing demand for biosimilars. North America led the market due to the growing use of biologics....
November 01, 2025
The single-cell biotherapeutics market is growing because single-cell technologies have accomplished significant achievements in diagnosing and treating different tumors, such as breast tumors, lung tumors, and gliomas....